RWL - ETF AI Analysis
Top Page
Invesco S&P 500 Revenue ETF (RWL)
Rating:72Outperform
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has shown solid gains so far this year and over the past few months, indicating positive recent momentum.
Balanced Sector Mix
Holdings are spread across health care, financials, technology, consumer, industrial, and energy companies, which helps reduce reliance on any single sector.
Large Asset Base
The fund manages a substantial amount of money, which can support liquidity and trading efficiency for investors.
Negative Factors
High U.S. Concentration
Almost all of the ETF’s assets are invested in U.S. companies, offering very little geographic diversification.
Mixed Performance Among Top Holdings
While some major positions like Amazon, Walmart, and Exxon Mobil have been strong, others such as Apple, CVS Health, Berkshire Hathaway, Microsoft, and JPMorgan have recently lagged.
Moderate Expense Ratio
The fund’s fee is higher than many low-cost index ETFs, which can slightly reduce long-term returns.
RWL vs. SPDR S&P 500 ETF (SPY)
AUM8.89B
RegionNorth America
Expense Ratio0.39%
Beta0.75
IssuerInvesco
Inception DateFeb 19, 2008
Dividend Yield1.26%
Asset ClassEquity
Index TrackedS&P 500 Revenue-Weighted Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume194,947
30 Day Avg. Volume275,526
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
142.27Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering502
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
RWL Summary
RWL is the Invesco S&P 500 Revenue ETF, which follows the S&P 500 Revenue-Weighted Index. Instead of giving more weight to the biggest companies by stock size, it tilts toward companies that bring in the most sales. It holds many well-known U.S. names like Amazon and Walmart, and spreads your money across many sectors such as health care, finance, and technology. Someone might invest in RWL for broad diversification in large U.S. companies with a focus on strong revenue. A key risk is that its value can go up or down with the overall stock market.
How much will it cost me?The Invesco S&P 500 Revenue ETF (RWL) has an expense ratio of 0.39%, meaning you’ll pay $3.90 per year for every $1,000 invested. This is slightly higher than the average for passively managed ETFs because it uses a unique revenue-weighted strategy rather than traditional market-cap weighting, which requires more specialized management.
What would affect this ETF?The Invesco S&P 500 Revenue ETF (RWL) could benefit from strong consumer spending and technological advancements, as its top holdings include companies like Walmart, Amazon, and Apple, which are leaders in their sectors. However, rising interest rates or economic slowdowns could negatively impact sectors like Financials and Consumer Cyclical, which make up significant portions of the ETF's exposure. Additionally, regulatory changes in healthcare or technology could pose risks to major holdings such as UnitedHealth and Microsoft.
RWL Top 10 Holdings
RWL’s story is all about big U.S. revenue machines spread across health care, retail, tech, and energy. Amazon and Walmart are doing the heavy lifting, with both stocks rising and giving the fund a solid consumer backbone. UnitedHealth has been a recent bright spot, while CVS is lagging and acting like a small anchor in the health care sleeve. Apple remains steady, keeping the tech engine humming, but Microsoft’s mixed performance has taken a bit of shine off Big Tech’s contribution. Exxon Mobil’s strong run adds an extra boost from the energy patch.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Amazon | 4.49% | $398.06M | $2.86T | 25.76% | 71 Outperform | |
| Walmart | 3.77% | $334.35M | $1.04T | 35.95% | 78 Outperform | |
| UnitedHealth | 3.11% | $276.24M | $359.98B | 27.30% | 72 Outperform | |
| CVS Health | 2.53% | $224.43M | $121.40B | 57.27% | 64 Neutral | |
| Apple | 2.46% | $218.70M | $4.33T | 38.45% | 79 Outperform | |
| Berkshire Hathaway B | 1.83% | $162.13M | $1.05T | -5.26% | 66 Neutral | |
| Centene | 1.61% | $143.09M | $29.29B | 0.58% | 58 Neutral | |
| Exxon Mobil | 1.61% | $142.78M | $624.35B | 37.61% | 74 Outperform | |
| Cigna | 1.57% | $139.73M | $78.96B | -1.13% | 72 Outperform | |
| McKesson | 1.57% | $139.01M | $88.31B | 6.82% | 62 Neutral |
RWL Technical Analysis
Positive
―
Price Trends
119.01
Positive
118.39
Positive
113.77
Positive
Market Momentum
1.60
Negative
70.82
Negative
88.20
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For RWL, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 122.89, equal to the 50-day MA of 119.01, and equal to the 200-day MA of 113.77, indicating a bullish trend. The MACD of 1.60 indicates Negative momentum. The RSI at 70.82 is Negative, neither overbought nor oversold. The STOCH value of 88.20 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for RWL.
RWL Peer Comparison
Comparison Results
Performance Comparison
RWL
Invesco S&P 500 Revenue ETF
125.07
25.52
25.64%
MGC
Vanguard Mega Cap ETF
―
―
―
PRF
Invesco FTSE RAFI US 1000 ETF
―
―
―
SPYI
NEOS S&P 500 High Income ETF
―
―
―
QYLD
Global X NASDAQ 100 Covered Call ETF
―
―
―
VONE
Vanguard Russell 1000 ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents